The Association of the British Pharmaceutical Industry’s (ABPI’s) 2026 flagship Competitiveness Report finds the UK has begun to reverse years of decline. However, the Association cautions that sustained delivery of government commitments will now determine whether the recovery holds. Since September 2025, the global pharmaceutical industry has committed an additional £2 ($2.7) billion investment into […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!